Antitumor effects of histone deacetylase inhibitor suberoylanilide hydroxamic acid in epidermal growth factor receptor-mutant non-small-cell lung cancer lines in vitro and in vivo

CM082 , a novel angiogenesis inhibitor, enhances the antitumor activity of gefitinib on epidermal growth factor receptor mutant non‐small cell lung cancer in vitro and in vivo

Thoracic Cancer ◽

10.1111/1759-7714.13430 ◽

2020 ◽

Vol 11 (6) ◽

pp. 1566-1577 ◽

Cited By ~ 1

Author(s):

Kun Zhang ◽

Lili Wang ◽

Aili Wei ◽

Xinfei Jia ◽

Xiaoqing Liu

Keyword(s):

Lung Cancer ◽

Angiogenesis Inhibitor ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Epidermal Growth ◽

Anlotinib combined with gefitinib can significantly improve the proliferation of epidermal growth factor receptor-mutant advanced non-small cell lung cancer in vitro and in vivo

Translational Lung Cancer Research ◽

10.21037/tlcr-21-192 ◽

2021 ◽

Vol 10 (4) ◽

pp. 1873-1888

Author(s):

Tao Li ◽

Yuxian Qian ◽

Chenfei Zhang ◽

Junji Uchino ◽

Mariano Provencio ◽

...

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Epidermal Growth ◽

Epidermal growth factor receptor (EGFR) inhibitor PD153035 reverses ABCG2-mediated multidrug resistance in non-small cell lung cancer: In vitro and in vivo

Cancer Letters ◽

10.1016/j.canlet.2018.02.040 ◽

2018 ◽

Vol 424 ◽

pp. 19-29 ◽

Cited By ~ 25

Author(s):

Guan-Nan Zhang ◽

Yun-Kai Zhang ◽

Yi-Jun Wang ◽

Pranav Gupta ◽

Charles R. Ashby ◽

...

Keyword(s):

Lung Cancer ◽

Multidrug Resistance ◽

Growth Factor Receptor ◽

Small Cell ◽

Egfr Inhibitor ◽

Small Cell Lung ◽

Epidermal Growth

Overcoming acquired resistance of epidermal growth factor receptor‐mutant non–small cell lung cancer cells to osimertinib by combining osimertinib with the histone deacetylase inhibitor panobinostat (LBH589)

Cancer ◽

10.1002/cncr.32744 ◽

2020 ◽

Vol 126 (9) ◽

pp. 2024-2033 ◽

Cited By ~ 7

Author(s):

Hongjing Zang ◽

Guoqing Qian ◽

Dan Zong ◽

Songqing Fan ◽

Taofeek K. Owonikoko ◽

...

Keyword(s):

Lung Cancer ◽

Histone Deacetylase Inhibitor ◽

Acquired Resistance ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Deacetylase Inhibitor ◽

Epidermal Growth ◽

C225 anti-epidermal growth factor receptor (EGFR) monoclonal antibody sensitizes human non-small cell lung cancer to both radiation and chemotherapy cytotoxicity in-vitro and in-vivo

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/s0360-3016(01)02162-9 ◽

2001 ◽

Vol 51 (3) ◽

pp. 187 ◽

Cited By ~ 2

Author(s):

B. Helfrich ◽

D. Raben ◽

D. Chan ◽

L. Garcia ◽

T. Shogun ◽

...

Keyword(s):

Lung Cancer ◽

Monoclonal Antibody ◽

Growth Factor ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Epidermal Growth

Abstract 2587: A novel covalent inhibitor of mutant but not wild-type (WT) epidermal growth factor receptor (EGFR) has activity in vitro and in vivo in non-small cell lung cancer (NSCLC) models

10.1158/1538-7445.am2015-2587 ◽

2015 ◽

Author(s):

Pedro J. Beltran ◽

Jinghui Zhan ◽

Petia Mitchell ◽

Ryan P. Wurz ◽

Liping Pettus ◽

...

Keyword(s):

Lung Cancer ◽

Growth Factor Receptor ◽

Small Cell ◽

Wild Type ◽

Small Cell Lung ◽

Epidermal Growth ◽

Covalent Inhibitor

Notch-1 contributes to epidermal growth factor receptor tyrosine kinase inhibitor acquired resistance in non-small cell lung cancer in vitro and in vivo

European Journal of Cancer ◽

10.1016/j.ejca.2013.07.007 ◽

2013 ◽

Vol 49 (16) ◽

pp. 3559-3572 ◽

Cited By ~ 45

Author(s):

Mian Xie ◽

Chao-Sheng He ◽

Shen-Hai Wei ◽

Li Zhang

Keyword(s):

Receptor Tyrosine Kinase ◽

Kinase Inhibitor ◽

Acquired Resistance ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Notch 1 ◽

Epidermal Growth

Efficacy of erlotinib and its effects on the quality of life of older patients with epidermal growth factor receptor‐mutant non‐small cell lung cancer: A prospective, multicenter, dose‐modification study

Geriatrics and Gerontology International ◽

10.1111/ggi.14243 ◽

2021 ◽

Author(s):

Yukari Tsubata ◽

Takeshi Masuda ◽

Kosuke Hamai ◽

Masaya Taniwaki ◽

Akari Tanino ◽

...

Keyword(s):

Quality Of Life ◽

Lung Cancer ◽

Older Patients ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Epidermal Growth ◽

Immune checkpoint inhibitors in epidermal growth factor receptor mutant non-small cell lung cancer: Current controversies and future directions

Lung Cancer ◽

10.1016/j.lungcan.2017.11.009 ◽

2018 ◽

Vol 115 ◽

pp. 12-20 ◽

Cited By ~ 59

Author(s):

Ross A. Soo ◽

Sun Min Lim ◽

Nicholas L. Syn ◽

Rebecca Teng ◽

Richie Soong ◽

...

Keyword(s):

Lung Cancer ◽

Immune Checkpoint Inhibitors ◽

Checkpoint Inhibitors ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Future Directions ◽

Epidermal Growth ◽

First-line osimertinib in patients with epidermal growth factor receptor–mutant non–small-cell lung cancer and with a coexisting low allelic fraction of Thr790Met

European Journal of Cancer ◽

10.1016/j.ejca.2021.09.039 ◽

2021 ◽

Vol 159 ◽

pp. 174-181

Author(s):

Margarita Majem ◽

Ivanna Sullivan ◽

Santiago Viteri ◽

Guillermo López-Vivanco ◽

Manuel Cobo ◽

...

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

Epidermal Growth ◽

Receptor Mutant ◽

Allelic Fraction